The current valuation score of ACADIA Pharmaceuticals Inc is 7.23, ranking 248 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 9.70, which is 966.03% below the recent high of 103.35 and 22399.40% above the recent low of -2161.97.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.